Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
Sam Altman reportedly backs $1B round for AI healthcare startup Retro Biosciences
The Financial Times today cited sources as saying that OpenAI Chief Executive Sam Altman is participating in the investment.
Sam Altman-Backed Retro Biosciences Raising $1 Billion to Extend Human Lifespan
Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through ...
Yahoo Finance9d
Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan
OpenAI CEO Sam Altman is doubling down on Retro Biosciences, a biotech startup based in San Francisco that wants humans to live 10 years longer than what it calls a healthy human lifespan.
Sam Altman-backed Retro Biosciences to raise $1bn for project to extend human life
Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...
GIGAZINE13d
Retro Bioscience, a startup researching AI-based treatments to extend human lifespan by 10 years, raises $1 billion in funding from OpenAI and others
Retro Biosciences, a startup that aims to use AI to aid in drug development, is reportedly raising $1 billion to support its research, with investors including OpenAI, which has previously backed ...
Forbes19d
The Prototype: OpenAI And Retro Biosciences Made An AI Model For Bioengineering
OpenAI teamed up with Retro Biosciences to build a machine learning model focused on generating new proteins. The new model, called GPT-4b, is a custom version of OpenAI’s GPT-4o model built ...